:

CHINESE AI STARTUPS RAISE $16.2B IN Q1, UP 185% YOY

AI DESK1 MIN READ
FRI, MAY 22, 2026

■ AI-SUMMARIZED FROM 4 SOURCES ▸ TIMELINE

Chinese AI startups secured $16.2 billion in funding during the first quarter of 2026, nearly tripling year-over-year gains. The surge reflects accelerating investor appetite for homegrown AI labs across the region.

According to Zero2IPO Research, Q1 2026 marked a significant inflection point for Chinese artificial intelligence funding. The 185% year-over-year increase demonstrates sustained momentum in the sector despite global economic uncertainties. Moonshot, Z.ai, and MiniMax led the funding wave, securing substantial capital rounds from domestic and international investors. These three AI labs represent the vanguard of China's push to develop competitive large language models and generative AI platforms. The quarter's performance signals growing confidence in Chinese AI capabilities and suggests investor conviction that domestic startups can compete globally. Funding velocity indicates capital flowing broadly across the sector rather than concentrating in a handful of unicorns. The surge underscores China's strategic focus on AI development as a national priority, with private investment aligning behind government initiatives to build indigenous AI infrastructure and reduce reliance on foreign models.

■ SOURCES

TechmemeTechmemeTechmemeTechmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

12H AGOAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

12H AGOAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

20H AGOAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.